Canadian Internal Medicine Ultrasound (CIMUS) Expert Consensus Statement on the Use of Lung Ultrasound for the Assessment of Medical Inpatients With Known or Suspected Coronavirus Disease 2019.
Canadian Internal Medicine Ultrasound (CIMUS) Expert Consensus Statement on the Use of Lung Ultrasound for the Assessment of Medical Inpatients With Known or Suspected Coronavirus Disease 2019.
复制标题
DOI：
10.1002/jum.15571
复制
发表时间：
2021-09
期刊：
影响因子：
--
通讯作者：
Liteplo AS
中科院分区：
文献类型：
--
作者：
Ma IWY;Hussain A;Wagner M;Walker B;Chee A;Arishenkoff S;Buchanan B;Liu RB;Mints G;Wong T;Noble V;Tonelli AC;Dumoulin E;Miller DJ;Hergott CA;Liteplo AS
就使用肺部超声(LU)评估2019年已知或疑似冠状病毒病的有症状全科住院患者达成共识声明(新冠肺炎)。我们的陆路专家小组由14名多学科的国际专家组成。专家们在3轮投票中选出了26条建议的强度，分别为“强”、“弱”或“不推荐”。对于不建议达成共识的建议，进行了第四轮审议，以确定这些建议的力度，并审议了另外两项建议。在26项建议中，第一轮6项，第二轮13项，第三轮7项，专家达成共识。由于存在冗余，四项建议被删除。在第四轮会议上，专家们审议了4项达成共识的建议，即不推荐和另外2种情况；就其中4项达成了共识。我们的最后建议由24项协商一致声明组成；其中两项建议的力度没有达成协商一致。对于已知或疑似新冠肺炎的有症状内科住院患者，我们建议使用LU来：(1)支持肺炎的诊断，但不诊断新冠肺炎；(2)排除与超声特征有关的问题；(3)监测患者的临床状态变化；(4)避免对替代诊断或重叠诊断的预试验概率较低的患者进行不必要的额外成像。我们不建议使用逻辑单元来指导入院和出院决定。如果患者的临床情况没有改变，我们不推荐常规的连续LU治疗。
To develop a consensus statement on the use of lung ultrasound (LUS) in the assessment of symptomatic general medical inpatients with known or suspected coronavirus disease 2019 (COVID‐19). Our LUS expert panel consisted of 14 multidisciplinary international experts. Experts voted in 3 rounds on the strength of 26 recommendations as “strong,” “weak,” or “do not recommend.” For recommendations that reached consensus for do not recommend, a fourth round was conducted to determine the strength of those recommendations, with 2 additional recommendations considered. Of the 26 recommendations, experts reached consensus on 6 in the first round, 13 in the second, and 7 in the third. Four recommendations were removed because of redundancy. In the fourth round, experts considered 4 recommendations that reached consensus for do not recommend and 2 additional scenarios; consensus was reached for 4 of these. Our final recommendations consist of 24 consensus statements; for 2 of these, the strength of the recommendations did not reach consensus. In symptomatic medical inpatients with known or suspected COVID‐19, we recommend the use of LUS to: (1) support the diagnosis of pneumonitis but not diagnose COVID‐19, (2) rule out concerning ultrasound features, (3) monitor patients with a change in the clinical status, and (4) avoid unnecessary additional imaging for patients whose pretest probability of an alternative or superimposed diagnosis is low. We do not recommend the use of LUS to guide admission and discharge decisions. We do not recommend routine serial LUS in patients without a change in their clinical condition.
登录
查看更多内容
影响因子：
19.7
作者：
Caruso, Damiano;Zerunian, Marta;Laghi, Andrea
通讯作者：
Laghi, Andrea
影响因子：
1.9
作者：
Gargani, Luna;Volpicelli, Giovanni
通讯作者：
Volpicelli, Giovanni
DOI：
10.1177/0846537120913033
发表时间：
2020-05-01
影响因子：
3.1
作者：
Dai, Wei-cai;Zhang, Han-wen;Lin, Fan
通讯作者：
Lin, Fan
影响因子：
5.9
作者：
Chung, Mi Sun;Lee, Eun Jung;Byun, Jun Soo
通讯作者：
Byun, Jun Soo
影响因子：
4
作者：
Artifoni, Mathieu;Danic, Gwenvael;Lecomte, Raphael
通讯作者：
Lecomte, Raphael